Skip to main content

HYZON INVESTOR ALERT

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hyzon To Contact Him Directly To Discuss Their Options

NEW YORK - (NewMediaWire) - September 30, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hyzon Motors Inc. (“Hyzon” or the “Company”) (NASDAQ: HYZN).

If you suffered losses exceeding $50,000 investing in Hyzon stock or options and would like to discuss your legal rights,call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330(Ext. 1310).You may alsoclick here for additional information: http://www.faruqilaw.com/HYZN.

There is no cost or obligation to you.

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.

On September 28, 2021, market analyst Blue Orca Capital published a report regarding Hyzon that alleged that the largest customer of Hyzon appears to be a fake Chinese shell company.

Following this news, Hyzon’s shares fell sharply during intraday trading on September 28, 2021, down over 28%.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.


 

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.09
+3.14 (1.44%)
AAPL  259.58
+1.13 (0.44%)
AMD  234.99
+4.76 (2.07%)
BAC  51.76
+0.66 (1.29%)
GOOG  253.73
+1.20 (0.48%)
META  734.00
+0.59 (0.08%)
MSFT  520.56
+0.02 (0.00%)
NVDA  182.16
+1.88 (1.04%)
ORCL  280.07
+7.41 (2.72%)
TSLA  448.98
+10.01 (2.28%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.